Articles and Blogs

In 2024, the health care M&A marketplace remained dynamic with established industry players and disruptive new entrants engaging in a variety of transactions despite continuing inflation, fluctuating interest rates and a contentious presidential election creating significant uncertainty for providers and investors alike. As Hall Render’s Health Transactions team reflects on 2024 and looks ahead... READ MORE

On March 13, 2024, Indiana joined a growing number of states in enacting health care merger notification laws when Governor Eric Holcomb signed Senate Enrolled Act No. 9 (“SEA 9”) into law. SEA 9 places increased scrutiny on health care mergers and acquisitions throughout the state by requiring certain health care entities involved in... READ MORE

The U.S. Department of Justice (“DOJ”) recently unveiled a department-wide Safe Harbor Policy for voluntary self-disclosures made in the mergers and acquisition (“M&A”) process. This Safe Harbor Policy (“Policy”) is aimed at incentivizing acquiring companies to identify and timely disclose misconduct discovered during the due diligence and post-acquisition integration process. Acquiring companies that disclose... READ MORE

Mergers and acquisitions in the health care industry present unique challenges that are not often present when undertaking similar transactions in other industries. Because of health care’s highly regulated nature, parties may falter if a health care transaction is not reviewed and negotiated carefully with respect to the distinct concerns that health care presents.... READ MORE

Mergers and acquisitions in the health care industry present unique challenges that are not often present when undertaking similar transactions in other industries. Because of health care’s highly regulated nature, parties may falter if a health care transaction is not reviewed and negotiated carefully with respect to the distinct concerns that health care presents. ... READ MORE

The events caused by COVID-19 and the pandemic’s ripple effects has certainly caused pause and required a renewed approach to most of life’s activities. Shockingly, legal due diligence conducted in a health care M&A transaction is not immune from such pause and reassessment. New considerations of novel or previously dormant factors will be required... READ MORE